# DALFAMPRIDINE
> **ANDA206811** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2017-01-23
## Drug
- **FDA Application Number:** ANDA206811
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DALFAMPRIDINE
- **Generic name:** DALFAMPRIDINE
- **Active ingredients:** DALFAMPRIDINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2017-01-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206811)
---
*MORVS · CC0 1.0*